Advertisement

Greg LeMond, 3-time Tour de France winner, diagnosed with leukemia

Greg LeMond, 3-time Tour de France winner, diagnosed with leukemia
Former cyclist Greg LeMond is being treated for a treatable form of bone marrow cancer. Photo by Steve Selwood/Wikimedia Commons

June 7 (UPI) -- Greg LeMond, a three-time champion of cycling's Tour de France, was diagnosed with a treatable former of cancer, he announced on his personal website.

LeMond wrote a post to detail the diagnosis of chronic myelogenous leukemia on Team-LeMond.com. He said the uncommon type of cancer, which occurs inside bones where blood cells are made, is not life-threatening or debilitating.

Advertisement

LeMond, 60, won the Tour de France in 1986, 1989 and 1990. He also was a two-time world champion. The Lakewood, Calif., native was inducted into the United States Bicycling Hall of Fame in 1996.

"I had been experiencing a few weeks of fatigue, which prompted me to go in for a check-up, which included some blood work," LeMond wrote.

RELATED National Bike to Work Day started in 1955 to promote healthy commuting

"Following a series of tests and a bone marrow biopsy, which was completed last week, I received my formal diagnosis last Friday."

Advertisement

LeMond said he started chemotherapy last week and he expects to start feeling better in a few weeks. He said his doctors at the University of Tennessee told him he should be in remission within a few months.

"The long-term prognosis is very favorable," Lemond wrote. "I am fortunate to have a great team of doctors and the full support of my family, friends and colleagues at LeMond Bicycles."

RELATED World cycling body aids in evacuation of 165 Afghans fleeing Taliban

LeMond said he planned to travel to France in July for the upcoming Tour de France, but is working on an "alternate plan." He expects to return to the Tour de France next summer.

The 2022 Tour de France will run July 1-24 from Copenhagen, Denmark, to Paris.

Advertisement

Latest Headlines

Advertisement
Advertisement

Follow Us

Advertisement